Oxford, United Kingdom

Raymond Paul Beckett

This inventor holds 38 USPTO granted patents, primarily in Antimicrobial Agents. Top assignees: British Biotech Pharmaceuticals Limited, De Novo Pharmaceuticals Limited, British Biotech. Active years: 1997-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Raymond Paul Beckett. Retrieved from https://idiyas.com/inventor/raymond-paul-beckett

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 71.1

Average Co-Inventor Count = 3.8

ph-index = 7

Forward Citations = 137(Granted Patents)


Location History:

  • Cowley, GB (1997 - 2008)
  • Oxford, GB (1997 - 2008)

Company Filing History:


Years Active: 1997-2008

Loading Chart...
Areas of Expertise:
Antimicrobial Agents
Antibacterial Agents
Bacterial Enzyme Inhibitors
Metalloproteinase Inhibitors
Hydroxamic Acid Derivatives
Succinyl Hydroxamic Acid
N-Formyl Hydroxylamine Derivatives
Cytokine Production Inhibitors
Natural Amino Acid Derivatives
Hydroxamic Acid Inhibitors
Derivatives of Succinamide
38 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Raymond Paul Beckett

Introduction

Raymond Paul Beckett, an innovative inventor based in Oxford, GB, has made significant contributions to the field of pharmacology through his research and development of antibacterial and antimicrobial agents. With a remarkable portfolio of 38 patents, he has demonstrated a commitment to advancing healthcare solutions.

Latest Patents

Among his latest patents are groundbreaking compounds that serve as antibacterial agents. These include formulations that possess the capacity to inhibit the activity of bacterial PDF enzyme, showcasing his in-depth understanding of biochemical interactions. His antimicrobial agents encompass compounds that exhibit both antibacterial and antiprotozoal activities, displaying versatile applications in treating various infections. The intricate formulas he has developed illustrate a sophisticated approach to medicinal chemistry.

Career Highlights

Throughout his career, Beckett has held pivotal roles in several esteemed organizations, such as British Biotech Pharmaceuticals Limited and De Novo Pharmaceuticals Limited. His work in these companies has been instrumental in driving forward research initiatives focused on novel therapeutic compounds. His extensive body of work stands as a testament to his innovative spirit and dedication to improving healthcare through scientific advancements.

Collaborations

Raymond Paul Beckett has had the opportunity to collaborate with notable professionals in the field, including Mark Whittaker and Andrew Miller. These collaborations have fostered a dynamic exchange of ideas and have resulted in the development of transformative health solutions.

Conclusion

In conclusion, Raymond Paul Beckett exemplifies the qualities of an exceptional inventor within the pharmaceutical landscape. His numerous patents reflect a dedication to innovation that addresses critical health challenges. As the field of medicine continues to evolve, Beckett's contributions will surely inspire future advancements in therapeutic development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…